Moody Aldrich Partners’s CVS Health CVS Stock Holding History

Moody Aldrich Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,125	Closed	-$1.23M	–	149
2022 Q1	$1.23M	Buy	+12,125	New	+$1.27M	0.17%	101

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moody Aldrich Partners's CVS Position: Q2 2022 in Review

Moody Aldrich Partners sold out of CVS Health (CVS) in Q2 2022, closing a stake of 12,125 shares — an estimated $1.23M sold.

Moody Aldrich Partners first reported a position in CVS in Q1 2022 and held it in 1 quarter. The position peaked at $1.23M in Q1 2022. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Moody Aldrich Partners reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
Moody Aldrich Partners sold 12,125 CVS Health shares in Q2 2022, an estimated $1.23M.
Moody Aldrich Partners first reported a position in CVS Health in Q1 2022 and held it in 1 quarter.
Moody Aldrich Partners's CVS Health position peaked at $1.23M in Q1 2022.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Moody Aldrich Partners's 13F filing for Q2 2022, filed 18 Jul 2022.